Company
Headquarters: Lanzhou, China
Employees: 298
CN¥3.06 Billion
CNY as of Jan. 1, 2024
US$430.6 Million
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd researches, develops, produces, and sells Chinese medicines and health food. It offers Yuanhu Zhitong dropping pills, Qiwei Wenyang capsules, Maxing Zhike capsules, Suanzaoren oil dropping pills, Xiaoshuan Tongluo tablets, Xiaoyanlidan tablets, Compound Danshen tablets, Snage films, Astragalus Angelica capsules, etc. The company was founded in 2002 and is based in Lanzhou, China.
Top 1-year algo backtest: +313.24%
$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd has the following listings and related stock indices.
Stock: SZSE: 300534 wb_incandescent